Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Camurus

Camurus
1991 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
CAMX STOCK SYMBOL
$11.26 SHARE PRICE (As of Friday Closing)
Description

Camurus AB is a research and development focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer and endocrine diseases. The company has Europe, North America and Other geographical areas geographic segments. It derives the majority of its revenues from North America geographic segment. The company's product pipeline includes CAM2038, CAM2029, CAM2032 product candidates.

Website
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Ideon Science Park
  • SE-223 70
  • Lund
  • Sweden

+46 046-286 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Camurus’s full profile, request a free trial.

Camurus Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$5.95 - $11.28 $570M $11.03 -$0.73 88.7K 51.6M

Camurus Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 394,772 261,337 568,976 417,332
Revenue 8,415 5,668 6,354 13,274
EBITDA (39,405) (32,499) (28,015) (11,545)
Net Income (32,757) (26,971) (22,298) (9,452)
Total Assets 57,748 40,576 58,135 70,247
Total Debt 2,677 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Camurus Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Camurus‘s full profile, request access.

Request full access to PitchBook

Camurus Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Orexo Formerly VC-backed Uppsala, Sweden 000 000.00 00000000 000.00
00000 000000000000 Formerly PE-Backed Mumbai, India 00000 00000 00000000 00000
00000 & 00. Corporation Kenilworth, NJ 00000
000000-0000000 000 Corporation Karachi, Pakistan 0000
00000000 Corporation Basel, Switzerland 000000 000000000000
To view this company’s complete list of competitors, request access »

Camurus Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Camurus‘s full profile, request access.

Request full access to PitchBook

Camurus Executive Team (4)

Name Title Board
Seat
Contact
Info
Fredrik Tiberg Ph.D Chief Executive Officer, Head of Research & President
Eva Pinotti-Lindqvist Chief Financial Officer
Fredrik Joabsson Chief Business Development Officer
Richard Jameson Chief Commercial Officer